Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Solid Tumor, Adult × Tiragolumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma, Squamous Cell 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor, Adult 1 Melanoma 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma 1 Breast Neoplasms 1 Advanced Liver Cancers 1

Interventions

pembrolizumab 2 toripalimab 1 tislelizumab 1 spartalizumab 1 sotorasib 1 peposertib 1 pazopanib 1 patritumab deruxtecan 1 palbociclib 1 lenvatinib 1 atezolizumab 1 abemaciclib 1 Trastuzumab 1 Tiragolumab 1 Fulvestrant 1 Cryosurgery 1 Catalytic Domain 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06003621 2024-11-15

MoST-TAP

Omico

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡